V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005039 | 320003415 | 1.6 | 0 | Palliative (P) | 2015-11-10 | 2017-08-31 | CNS LGG 2004 03 cons vinc +cyclo | 2 | Y | 320015238 | NOT MATCHED |
| 320005040 | 320003416 | 1.67 | null | Curative (C) | 2013-12-15 | 2013-12-15 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320015241 | CISPLATIN + RT |
| 320005041 | 320003419 | 1.69 | 81.5 | Curative (C) | 2013-05-27 | 2013-05-28 | Cetuximab 7 day (Cycle 1) | N | null | 320015242 | CETUXIMAB |
| 320005042 | 320003421 | 1.66 | 67.5 | Palliative (P) | 2014-08-03 | 2014-08-28 | GemCarbo Days 1+8 | N | N | 320015242 | GEMCARBO |
| 320005043 | 320003421 | 1.79 | 65.8 | Palliative (P) | 2017-01-21 | 2017-01-21 | CARBOPLATIN + GEMCITABINE | 02 | N | 320015242 | GEMCARBO |
| 320005044 | 320003423 | 1.47 | 81 | Neo-adjuvant (N) | 2016-06-24 | 2016-07-06 | Trial Unspecified | 02 | N | 320015268 | TRIAL |
| 320005045 | 320003423 | 1.72 | 72.9 | Palliative (P) | 2017-11-24 | 2017-12-06 | Cisplatin +Fluorouracil (2 wk) | 2 | N | 320015268 | CISPLATIN + FLUOROURACIL |
| 320005046 | 320003424 | 1.85 | 77 | Palliative (P) | 2018-07-06 | 2018-07-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320015279 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005049 | 320005555 | 1.8 | 25.4 | Palliative (P) | 2017-09-16 | 2017-09-23 | GemCarbo Days 1+8 | N | N | 320015290 | GEMCARBO |
| 320005050 | 320003427 | null | 111.1 | Palliative (P) | 2017-11-29 | 2017-12-08 | Carboplatin + Liposomal Doxorubicin | N | N | 320015290 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005051 | 320003428 | 1.69 | 62 | Palliative (P) | 2019-01-08 | 2019-01-08 | CETUXIMAB | N | N | 320015300 | CETUXIMAB |
| 320005052 | 320003429 | 1.68 | 89.2 | Curative (C) | 2017-09-27 | 2017-10-04 | Cisplatin + Radiotherapy | 02 | N | 320015303 | CISPLATIN + RT |
| 320005053 | 320003429 | 0 | null | Adjuvant (A) | 2017-08-22 | 2017-09-13 | CETUXIMAB | null | N | 320015303 | CETUXIMAB |
| 320005054 | 320003431 | 1.73 | 88.4 | Palliative (P) | 2018-10-10 | 2018-10-31 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320015307 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005055 | 320003431 | 1.74 | 93.4 | Palliative (P) | 2017-12-29 | 2018-01-06 | CARBOPLATIN + GEMCITABINE | N | N | 320015307 | GEMCARBO |
| 320005056 | 320003432 | 1.52 | 74 | Palliative (P) | 2016-12-10 | 2016-12-13 | CISPLATIN + FLUOROURACIL | N | Y | 320015317 | CISPLATIN + FLUOROURACIL |
| 320005057 | 320003432 | null | 75.3 | Palliative (P) | 2018-09-14 | 2018-09-15 | null | 02 | N | 320015317 | NOT MATCHED |
| 320005058 | 320007280 | 1.68 | 82 | Palliative (P) | 2016-11-01 | 2016-11-01 | Carboplatin + Liposomal Doxorubicin | N | Y | 320015321 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005059 | 320007280 | 1.7 | 94.6 | Palliative (P) | 2016-10-06 | 2016-10-30 | CETUXIMAB | N | N | 320015321 | CETUXIMAB |
| 320005060 | 320003433 | 1.7 | 95.9 | Palliative (P) | 2013-09-13 | 2013-11-06 | Trial Unspecified | N | null | 320015336 | TRIAL |
| 320005061 | 320003435 | 1.76 | null | Palliative (P) | 2015-12-29 | 2016-01-03 | Liposomal Doxorubicin 40mg/m2 | Y | N | 320015339 | LIPOSOMAL DOXORUBICIN |
| 320005062 | 320003436 | 1.62 | null | Palliative (P) | 2015-06-25 | 2015-07-05 | GemCarbo Days 1+8 | 02 | N | 320015339 | GEMCARBO |
| 320005063 | 320005564 | 1.67 | 17.95 | Disease modification (D) | 2016-01-15 | 2016-01-15 | GemCarbo Days 1+8 | 02 | N | 320015353 | GEMCARBO |
| 320005064 | 320003438 | 1.72 | 83 | Not known (9) | 2017-10-27 | 2017-11-14 | CISPLATIN + FLUOROURACIL | 02 | N | 320015360 | CISPLATIN + FLUOROURACIL |
| 320005065 | 320003439 | 1.75 | 80.5 | null | 2015-06-17 | 2015-06-26 | Liposomal Doxorubicin (Caelyx) | N | N | 320015363 | LIPOSOMAL DOXORUBICIN |
| 320005067 | 320003442 | 1.58 | 68 | Palliative (P) | 2015-06-23 | 2015-06-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320015371 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005068 | 320003443 | 1.85 | 102 | Palliative (P) | 2016-09-12 | 2016-09-12 | Carboplatin + Liposomal Doxorubicin | N | N | 320015373 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005069 | 320003444 | 1.69 | 106.8 | Curative (C) | 2015-03-23 | 2015-04-14 | Trial Unspecified | N | N | 320015373 | TRIAL |
| 320005070 | 320003446 | 1.84 | null | Curative (C) | 2017-02-24 | 2017-02-24 | Cisplatin | 1 | N | 320015379 | CISPLATIN |
| 320005071 | 320003447 | 1.7 | 82 | Neo-adjuvant (N) | 2018-03-10 | 2018-03-10 | Trial Unspecified | N | null | 320015382 | TRIAL |
| 320005072 | 320003448 | 1.75 | 78.7 | Palliative (P) | 2016-08-22 | 2016-08-22 | GEMCARBO | null | null | 320015390 | GEMCARBO |
| 320005073 | 320003449 | 1.61 | 74.6 | Curative (C) | 2018-03-02 | 2018-03-02 | CISPLATIN + RT | N | N | 320015393 | CISPLATIN + RT |
| 320005074 | 320003450 | 1.7 | 79.25 | Adjuvant (A) | 2018-03-11 | 2018-03-11 | Cisplatin | N | N | 320015393 | CISPLATIN |
| 320005075 | 320003451 | null | 82.05 | Adjuvant (A) | 2016-03-11 | 2016-04-02 | null | 02 | N | 320015398 | NOT MATCHED |
| 320005076 | 320003452 | 1.61 | 84.2 | Palliative (P) | 2018-08-14 | 2018-08-28 | GEMCARBO | Y | null | 320015403 | GEMCARBO |
| 320005077 | 320003453 | null | 63.5 | Palliative (P) | 2017-08-06 | 2018-01-11 | Trial Unspecified | 02 | N | 320015411 | TRIAL |
| 320005078 | 320005569 | 1.56 | 62.5 | Palliative (P) | 2018-05-23 | 2018-06-04 | Carboplatin + Liposomal Doxorubicin | N | N | 320015426 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005079 | 320003457 | 1.7 | 62.6 | Curative (C) | 2014-10-29 | 2014-11-24 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320015431 | CISPLATIN + RT |
| 320005080 | 320003457 | 1.8 | 65.2 | Palliative (P) | 2013-10-11 | 2013-11-05 | Cisplatin | 2 | Y | 320015431 | CISPLATIN |
| 320005081 | 320003458 | 1.71 | 59.3 | Curative (C) | 2015-05-18 | 2015-06-10 | CISPLATIN + RT | N | N | 320015443 | CISPLATIN + RT |
| 320005082 | 320003459 | 1.63 | 48.6 | Palliative (P) | 2016-08-21 | 2016-08-28 | Carboplatin + Liposomal Doxorubicin | N | N | 320015450 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005083 | 320003459 | null | 62 | Palliative (P) | 2018-06-27 | 2018-07-24 | Carboplatin + Liposomal Doxorubicin | N | null | 320015450 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005084 | 320003460 | 1.53 | 64.8 | null | 2015-09-23 | 2015-09-23 | Cisplatin | 02 | N | 320015456 | CISPLATIN |
| 320005085 | 320003461 | null | 106.2 | Palliative (P) | 2012-12-14 | 2015-07-15 | Carboplatin + Liposomal Doxorubicin | N | Y | 320015463 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005086 | 320005572 | 1.56 | 71 | Palliative (P) | 2015-12-20 | 2015-12-23 | EW EuroEwing 2012 Arm B VDC | N | N | 320015469 | TRIAL |
| 320005087 | 320003463 | 1.74 | 59.3 | Adjuvant (A) | 2013-07-03 | 2013-07-03 | GemCarbo Days 1+8 | 02 | N | 320015469 | GEMCARBO |
| 320005088 | 320003464 | 1.62 | 59.9 | Palliative (P) | 2016-07-28 | 2017-03-15 | Liposomal Doxorubicin (Caelyx) | 02 | Y | 320015477 | LIPOSOMAL DOXORUBICIN |
| 320005089 | 320003466 | 1.55 | 104.9 | Palliative (P) | 2017-06-25 | 2017-07-10 | Trial Unspecified | 2 | null | 320015477 | TRIAL |
| 320005090 | 320003466 | 1.7 | 89.7 | Palliative (P) | 2016-04-29 | 2016-05-14 | Liposomal Doxorubicin 40mg/m2 | N | Y | 320015477 | LIPOSOMAL DOXORUBICIN |
| 320005091 | 320003466 | null | 70.8 | Adjuvant (A) | 2015-08-28 | 2015-11-20 | Cisplatin | N | null | 320015477 | CISPLATIN |